M. Galotti

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines

U. Dafni, E. de Vries, M. Strijbos, 2022, ESMO open.

Methodological and reporting standards for quality of life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit.

M. Piccart, B. Gyawali, A. Bottomley, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Prioritising systemic cancer therapies applying ESMO’s tools and other resources to assist in improving cancer care globally: the Kazakh experience

E. de Vries, N. Cherny, N. Latino, 2022, ESMO open.

ESMO-Magnitude of Clinical Benefit Scale for Haematological Malignancies (ESMO-MCBS:H) Version 1.0.

M. Piccart, B. Gyawali, U. Dafni, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

ESMO Study on the Availability and Accessibility of Biomolecular Technologies in Oncology in Europe.

J. Bonastre, N. Latino, G. Bricalli, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.